BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25066804)

  • 1. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
    Hanly P; Soerjomataram I; Sharp L
    Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.
    Hanly PA; Sharp L
    BMC Cancer; 2014 Mar; 14():224. PubMed ID: 24670067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
    Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
    Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040.
    Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
    Appl Health Econ Health Policy; 2023 Nov; 21(6):877-889. PubMed ID: 37552416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran.
    Khorasani S; Rezaei S; Rashidian H; Daroudi R
    Asian Pac J Cancer Prev; 2015; 16(5):1845-50. PubMed ID: 25773835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
    Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
    Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach.
    Hanly P; Ortega-Ortega M; Soerjomataram I
    Curr Oncol; 2022 May; 29(5):3552-3564. PubMed ID: 35621677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study.
    Hanly P; Ahern M; Sharp L; Ursul D; Loughnane G
    Eur J Health Econ; 2022 Mar; 23(2):249-259. PubMed ID: 34417904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projecting productivity losses for cancer-related mortality 2011 - 2030.
    Pearce A; Bradley C; Hanly P; O'Neill C; Thomas AA; Molcho M; Sharp L
    BMC Cancer; 2016 Oct; 16(1):804. PubMed ID: 27756270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018.
    Rumgay H; Ortega-Ortega M; Sharp L; Lunet N; Soerjomataram I
    Cancer Epidemiol; 2023 Jun; 84():102365. PubMed ID: 37058915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison.
    Pearce A; Sharp L; Hanly P; Barchuk A; Bray F; de Camargo Cancela M; Gupta P; Meheus F; Qiao YL; Sitas F; Wang SM; Soerjomataram I
    Cancer Epidemiol; 2018 Apr; 53():27-34. PubMed ID: 29353153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
    Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):709-722. PubMed ID: 34329626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.
    Carter HE; Schofield DJ; Shrestha R
    PLoS One; 2016; 11(12):e0167521. PubMed ID: 27942032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of premature cancer-related mortality: a review and assessment of the evidence.
    Hanly P; Pearce A; Sharp L
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):355-77. PubMed ID: 24746223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of cancer in Europe 2018.
    Hofmarcher T; Lindgren P; Wilking N; Jönsson B
    Eur J Cancer; 2020 Apr; 129():41-49. PubMed ID: 32120274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the Economic Burden of Premature Mortality Caused by Cancer in Iran: 2006-2010.
    Karami-Matin B; Najafi F; Rezaei S; Khosravi A; Soofi M
    Asian Pac J Cancer Prev; 2016; 17(4):2131-6. PubMed ID: 27221907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006-2015.
    Rumisha SF; George J; Bwana VM; Mboera LEG
    PLoS One; 2020; 15(6):e0234300. PubMed ID: 32516340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs.
    Bencina G; Chami N; Hughes R; Weston G; Baxter C; Maciejczyk A; Popovic L; Karamousouli E; Salomonsson S
    J Med Econ; 2023; 26(1):254-261. PubMed ID: 36756852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
    Burns R; Leal J; Sullivan R; Luengo-Fernandez R
    Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.